- Clorox press release ( NYSE: CLX ): Q4 Non-GAAP EPS of $0.93 in-line.
- Revenue of $1.8B (flat Y/Y) misses by $60M .
- Gross margin of 37.1% was flat versus the year-ago quarter, due mainly to ongoing elevated commodity costs and manufacturing and logistics costs, offset by the benefits of pricing and cost savings initiatives.
- 2023 Outlook: Net sales are expected to be down 4% to up 2% compared to the prior year. Organic sales are expected to be down 3% to up 3%.
- Gross margin is expected to increase by about 200 basis points, primarily due to the combined benefit of pricing, cost savings and supply chain optimization, offset by continued cost inflation.
- Diluted EPS is expected to be between $3.10 and $3.47, or a decrease between 17% and 7%, respectively.
- Adjusted EPS is expected to be between $3.85 and $4.22, or a decrease of 6% to an increase of 3%, respectively.
- Shares -6.5% .
For further details see:
Clorox Non-GAAP EPS of $0.93 in-line, revenue of $1.8B misses by $60M